osteomalacia is a clinical condition defined by the failure of osteoid to mineralize in mature bone, leading to skeletal weakness and increased fracture risk. It is distinct from Osteoporosis, which involves a decrease in bone mass rather than a defect in the mineralization process itself. Physiologically, the condition is driven by insufficient calcium or phosphate availability, often secondary to vitamin D deficiency (E55.9), renal tubular acidosis (N25.89), or hypophosphatemia (E83.31). While often confused with rickets (which occurs in children before epiphyseal closure), osteomalacia specifically refers to the adult manifestation. Clinical subtypes include nutritional, renal, and drug-induced forms, each requiring specific biochemical workups to differentiate from other metabolic bone diseases.
Noun-forming suffix indicating a state or condition.
The word entered English in the 1830s as osteomalacia (noun), borrowed from Modern Latin, which combined the Greek roots for bone and softness. The root connects to related terms: osteology (study of bone) and malacology (study of soft-bodied mollusks).
🔀 ALIASES / ALTERNATE TERMS
Osteomalacic(clinical presentation of bone softening)
Adult Rickets(historical synonym for adult-onset mineralization defect)
⚠️ Coding Note: When coding osteomalacia, ensure the underlying etiology is sequenced as a secondary diagnosis if known (e.g., E55.9 or N25.0). Use site-specific codes if the condition is localized. For inpatient encounters, ensure the documentation supports the distinction between osteomalacia and osteoporosis, as the treatment pathways and DRG weights differ significantly. Always capture the specific metabolic cause to support medical necessity for high-cost laboratory testing.